Histomorphology and Immunohistochemistry of Gastrointestinal Stromal Tumors in a Malaysian Population |
Kkrishnappa, Purushotham
(Pathology, Medicine, International Medical University)
Loh, Eu Jhin (Pathology, Medicine, International Medical University) Mohamad, Ibtisam Binti (Department of Pathology, Hospital Tuanku Ja'afar) Tata, Mahadevan Deva (Department of Surgery, Hospital Tuanku Ja'afar) Akhilesh, Meenakshi (Pathology, Medicine, International Medical University) Palayan, Kandasami (Department of Surgery, Hospital Tuanku Ja'afar) |
1 | Amin MB, Ma CK, Linden MD, et al (1993). Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumours. Correlation with mitotic count and clinical outcome. Am J Clin Pathol, 4, 428-32. |
2 | Daniel R. Perez, Raymond E. Baser, Michael J. Cavnar, et al (2013). Tap et al blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol, 20, 593-9. DOI |
3 | DeMatteo RP, Michael C Heinrich, WA'el M, et al (2002). Clinical management of gastorintestinal stromal tumours: before and after STI-571. Human Pathol, 33, 466-77. DOI |
4 | Demetri GD, Benjamin RS, Blanke CD, et al (2007). NCCN Task force report: Management of patients with gastrointestinal stromal tumour (GIST)-update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw, 5, 1-29. DOI |
5 | Fletcher CD, Berman JJ, Corless C, et al (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 33, 459-65. DOI |
6 | Hasegawa T, Matsuno Y, Shimoda T, et al (2002). Gastrointestinal Stromal Tumour: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumour size and MIB-1 grade. Human Pathol, 6, 669-75. |
7 | Hirota S, Isozaki K, Moriyama Y, et al (1998). Gain-of-function mutation of c-kit in human gastrointestinal stromal tumours. Science, 279, 577-80. DOI |
8 | Jiang C, Hu WM, Liao FX, Yang Q, et al (2016). Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients. Onco Targets Therapy, 23, 877-83. |
9 | Jin Woong Cho, The Korean ESD Study Group (2016). Current Guidelines in the Management of Upper Gastrointestinal Subepithelial Tumors. Clin Endosc, ce.2015.096. |
10 | Khoo JJ, Gunn A (2005). A clinical and immunohistochemical study of gastrointestinal stromal tumours. Malaysian J Pathol, 27, 9-16. |
11 | Kim KM, Kang DW, Moon WS, et al (2005). Gastrointestinal stromal tumours in Koreans: its incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci, 20, 977. DOI |
12 | Markku Miettinen, Marii Sarlomo-Rikala, Jerzy Lasota (1999). Gastrointestinal stromal tumours: recent advances in understanding of their biology. Human Pathol, 10, 1213-20. |
13 | Markku Miettinen, Wa'el El-Rafai, Leslie H Sobin, et al (2002). Evaluation of malignancy and prognosis of gastrointestinal stromal tumours. a review. Human Pathol, 5, 478-83. |
14 | Miettinen M, Lasota J (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol, 23, 70-83. DOI |
15 | Steigen SE, Bjerkehagen B, Haugland HK, et al (2008). Diagnostic and prognostic markers of gastrointestinal stromal tumours in Norway. Modern Pathol, 21, 46-53. DOI |
16 | Allred DC, Harvey JM, Berardo M, et al (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11, 155-68. |
17 | Y Na Kang, Jung HR, Hwang I (2010). Clinicopathological and immunohistochemical features of gastrointestinal stromal tumours. Cancer Research Treat, 42, 135-43. DOI |
![]() |